IRIS
CIANI, ORIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.658
NA - Nord America 4.004
AS - Asia 1.731
SA - Sud America 29
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 18
AF - Africa 13
Totale 11.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.770
IT - Italia 2.556
IE - Irlanda 1.108
CN - Cina 607
GB - Regno Unito 453
UA - Ucraina 417
SG - Singapore 359
DE - Germania 284
CA - Canada 225
SE - Svezia 224
FI - Finlandia 202
TR - Turchia 196
HK - Hong Kong 156
VN - Vietnam 144
FR - Francia 94
KR - Corea 75
BG - Bulgaria 55
IN - India 55
CZ - Repubblica Ceca 52
KZ - Kazakistan 49
BE - Belgio 36
NL - Olanda 32
ES - Italia 20
RO - Romania 20
IR - Iran 18
EU - Europa 17
AU - Australia 16
CH - Svizzera 14
BR - Brasile 13
PT - Portogallo 13
AT - Austria 12
DK - Danimarca 10
JP - Giappone 10
AE - Emirati Arabi Uniti 9
PL - Polonia 9
MX - Messico 7
NO - Norvegia 7
RU - Federazione Russa 7
GR - Grecia 5
LT - Lituania 5
LV - Lettonia 5
PE - Perù 5
PH - Filippine 5
CL - Cile 4
EC - Ecuador 4
HU - Ungheria 4
ID - Indonesia 4
IL - Israele 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
PK - Pakistan 4
SA - Arabia Saudita 4
EG - Egitto 3
KG - Kirghizistan 3
MA - Marocco 3
TH - Thailandia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CO - Colombia 2
EE - Estonia 2
GE - Georgia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
GH - Ghana 1
KE - Kenya 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
PS - Palestinian Territory 1
PY - Paraguay 1
SM - San Marino 1
Totale 11.472
Salva come PNG Salva come JPEG
Città #
Dublin 1.104
Chandler 673
Milan 562
Jacksonville 334
Ann Arbor 258
Singapore 256
Southend 215
Rome 191
Toronto 189
Hong Kong 155
Redmond 149
New York 147
Dearborn 146
Beijing 139
Helsinki 133
Dong Ket 130
Wilmington 116
Ashburn 113
Houston 111
Lawrence 97
Modena 93
Boston 90
Boardman 84
Seoul 71
Izmir 68
Los Angeles 57
Naples 55
Redwood City 50
Almaty 49
Mountain View 48
Palombara Sabina 47
Seattle 41
Woodbridge 40
Fairfield 36
Frankfurt am Main 35
Munich 35
Bologna 33
Brussels 30
Bari 27
Fremont 27
Turin 25
Florence 22
Ottawa 22
Lappeenranta 21
Brno 20
Catania 19
Washington 18
Bucharest 16
Genoa 16
Hefei 16
Kunming 16
Nanjing 16
West Jordan 15
Guangzhou 14
Trieste 14
Chennai 13
Dallas 13
Jinan 13
Palermo 13
Robbiate 12
Napoli 11
Trento 11
Bonndorf 10
Falls Church 10
Norwalk 10
Shenyang 10
Torino 10
Darwin 9
Falkenstein 9
Monza 9
Nardò 9
Nuremberg 9
Padova 9
Paris 9
Vienna 9
Amsterdam 8
Bergamo 8
Lisbon 8
London 8
Pavia 8
Verona 8
Ardabil 7
Auburn Hills 7
Carrara 7
Cesa 7
Livorno 7
Messina 7
Monmouth Junction 7
Perugia 7
Riposto 7
Salerno 7
Santa Clara 7
Cento 6
Crotone 6
Desenzano Del Garda 6
Forlì 6
Nanchang 6
Novara 6
Olomouc 6
Piscataway 6
Totale 6.885
Salva come PNG Salva come JPEG
Nome #
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 322
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 301
Esiti di salute e performance del Servizio Sanitario Nazionale 298
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 259
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 234
I dispositivi medici in Italia: un settore, tanti mercati 229
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 206
EQ-5D-5L population norms for Italy 194
Gli esiti di salute del Servizio Sanitario Nazionale 175
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 164
Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis 162
Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis 157
Current and Future Trends in the HTA of Medical Devices 156
La dimensione del settore dei dispositivi medici 149
Gli esiti di salute del Servizio Sanitario Nazionale 148
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 148
Endpoint surrogati e politiche sanitarie: l’importanza di metodi di validazione adeguati 148
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration 147
The Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer 132
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 128
Surrogate endpoints in health technology assessment: an international review of methodological guidelines 126
Integrating HTA principles into procurement of medical devices: the Italian national HTA programme for medical devices 125
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 120
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 118
Patient-reported outcome measures in core outcome sets targeted overlapping domains but through different instruments 116
I processi di valutazione dei dispositivi medici e delle tecnologie sanitarie 114
Core outcome set in surgical oncology: why, what and how to measure 114
Valutare l’impatto dell’HTA come strumento di governo dell’innovazione tecnologica: modelli teorici e studi empirici 112
Surrogate endpoints: a key concept in clinical epidemiology 111
Comparing drug and non-drug technologies in comparative effectiveness research 111
Measuring value in health care: a comparative analysis of value-based frameworks 110
A scoping review of core outcome sets and their 'mapping' onto real-world data using prostate cancer as a case study 109
Mud-bath therapy in addition to usual care in bilateral knee osteoarthritis: economic evaluation alongside a randomized controlled trial 108
A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement 108
An economic perspective on urinary tract infection: the "costs of resignation" 107
Cost–effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma 107
Distinguishing features in the assessment of mHealth apps 103
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 103
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 103
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 101
Time to review the role of surrogate end points in health policy: state of the art and the way forward 101
European diabetes research and its funding, 2002–2013 101
Exercise training for chronic heart failure (ExTraMATCH II): why all data are not equal 96
The rise of rules: will the new regulation of medical devices make us safer? 96
Hospital-based HTA: quale valore per la valutazione delle tecnologie nelle Aziende Sanitarie italiane? 95
Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study 95
Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer 95
Broadening the concept of value: a scoping review on the option value of medical technologies 94
An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study 94
Introduction to economic evaluation and health technology assessment 92
La gestione dell'innovazione tecnologica in sanità: analisi e confronto di alcune politiche regionali in Italia 91
Determinants of demand for total hip and and knee arthroplasty: a systematic literature review 89
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study 89
Complete cytogenetic response and major molecular response as surrogate outcomes for overall survival in first-line treatment of chronic myelogenous leukemia: a case study for technology appraisal on the basis of surrogate outcomes evidence 89
Harnessing digital health technologies during and after the COVID-19 pandemic: context matters 89
Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms 88
Health technology assessment methods guidelines for medical devices: how can we address the gaps? the international federation of medical and biological engineering perspective 87
Coverage with evidence development for medical devices in Europe: can practice meet theory? 87
The evaluation of medical devices: are we getting closer to solve the puzzle? A review of recent trends 86
Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials 85
The impacts of diabetes research from 31 European Countries in 2002 to 2013 84
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework 83
Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany 83
Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials 83
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis 83
Esiti di salute e performance del Servizio Sanitario Nazionale 83
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy. 83
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 83
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study 81
A more evidence based approach to the use of surrogate end points in policy making 81
Value-based healthcare: il nuovo approccio di AIFA alla determinazione multidimensionale del valore 81
Urinary Tract Infections – An Economic Issue 79
Response to COVID-19: was Italy (un)prepared? 79
Quantitative body movement and gesture assessment in ergonomics. 77
Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer 77
Validation of surrogate end points for overall survival in advanced colorectal cancer: a harmonized approach is needed 76
Assessment of nonfatal myocardial infarction as a surrogate for all-cause and cardiovascular mortality in treatment or prevention of coronary artery disease: a meta-analysis of randomized clinical trials 76
Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses 75
Health technology assessment of medical devices: a survey of non-European union agencies 74
Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps 74
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges 73
Corona-regionalism? Differences in regional responses to COVID-19 in Italy 73
Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers 72
Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis 71
Linking the regulatory and reimbursement processes for medical devices: the need for integrated assessments 69
Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials 68
Value lies in the eye of the patients: the why, what, and how of patient-reported outcomes measures 66
Valorizzare gli esiti riferiti dal paziente : opportunità e sfide 65
The role of health technology assessment bodies in shaping drug development 65
Pervasive technology in Neonatal Intensive Care Unit: a prototype for newborns unobtrusive monitoring 63
A call for better reporting of trials using surrogate primary endpoints 61
Esiti di salute e performance del Servizio Sanitario Nazionale 60
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 54
Editorial: Near-infrared fluorescence guided surgery: state of the evidence from a health technology assessment perspective 50
Commentary: Nothing but a toothbrush for beginning the reduction of the postoperative costs in thoracic surgery 50
Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis 50
Validity of surrogate endpoints and their impact on coverage recommendations: a retrospective analysis across international Health Technology Assessment agencies 48
The importance of using the appropriate model for systematic reviews and meta-analyses-reply 48
The Coronavirus pandemic and inequality in Italy 47
The impact of surgical experience in VATS lobectomy on conversion and patient quality of life: results from a comprehensive national video-assisted thoracic surgical database 47
Totale 10.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.177 0 0 0 0 0 246 245 134 153 220 39 140
2020/20211.350 59 86 33 106 143 91 129 58 156 118 116 255
2021/20221.500 107 220 50 68 140 66 58 233 72 145 143 198
2022/20233.178 202 173 86 266 203 223 83 162 1.398 121 161 100
2023/20242.436 109 142 149 59 258 287 193 324 98 180 303 334
2024/2025872 108 71 228 172 179 114 0 0 0 0 0 0
Totale 11.865